期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
微创导管溶栓术联合利伐沙班治疗急性下肢深静脉血栓的临床疗效
1
作者 熊卫平 兰翠茹 +6 位作者 杜丛林 刘艳茹 盛华 胡庆龄 杨鑫磊 曹霞 余越 《中外医药研究》 2022年第3期36-38,共3页
目的:分析采用微创导管溶栓术(CDT)联合利伐沙班治疗急性下肢深静脉血栓的临床疗效。方法:选取2019年3月-2022年3月重庆市江津区第二人民医院收治的急性下肢深静脉血栓患者40例为观察对象,按治疗方法不同分为对照组与观察组,各20例。对... 目的:分析采用微创导管溶栓术(CDT)联合利伐沙班治疗急性下肢深静脉血栓的临床疗效。方法:选取2019年3月-2022年3月重庆市江津区第二人民医院收治的急性下肢深静脉血栓患者40例为观察对象,按治疗方法不同分为对照组与观察组,各20例。对照组予单纯利伐沙班治疗,观察组予微创CDT联合利伐沙班治疗。比较两组治疗前、治疗7 d后、1个月后的患侧与健侧大小腿周径差、髂股静脉再通情况、住院时间与并发症发生情况。结果:治疗前,两组大小腿周径差比较,差异无统计学意义(P>0.05);治疗7 d后,观察组大小腿周径差低于对照组,治疗1个月后,观察组周径差低于对照组,差异有统计学意义(P<0.05);观察组髂股静脉通畅评分低于对照组,住院时间短于对照组,差异有统计学意义(P<0.05);观察组并发症低于对照组,差异无统计学意义(P>0.05)。结论:微创CDT联合利伐沙班治疗急性下肢深静脉血栓能够有效降低大小腿周径差,加速血栓溶解,且不会增加并发症发生率,是一种安全、有效的治疗手段。 展开更多
关键词 急性下肢深静脉血栓 微创导管溶栓术 利伐沙班
下载PDF
铅门跟随技术对食管癌调强放疗计划质控的影响 被引量:1
2
作者 孙甫 兰翠茹 +2 位作者 熊卫平 李丛 吴府容 《医学信息》 2022年第4期133-136,共4页
目的研究铅门自动跟随技术对食管癌调强放疗计划的质控效果以及对放射性肺炎剂量体积指标的影响。方法选择我院2019年9月-2020年12月收治的胸中段食管癌患者20例,分别采用铅门跟随技术和铅门固定技术对患者的放疗计划进行重新设计,根据... 目的研究铅门自动跟随技术对食管癌调强放疗计划的质控效果以及对放射性肺炎剂量体积指标的影响。方法选择我院2019年9月-2020年12月收治的胸中段食管癌患者20例,分别采用铅门跟随技术和铅门固定技术对患者的放疗计划进行重新设计,根据患者的放疗计划将其分为铅门跟随技术组和铅门固定技术组,制定两种技术条件下的治疗计划,比较两组PTV、心脏、脊髓、肺及肺相关指标(V_(5)、V_(10)、V_(20)、V_(30)和V_(40))的剂量曲线,比较两组计划的靶区、危及器官和虚拟器官的γ通过率。结果两组PTV、心脏、脊髓、肺及肺相关指标(V_(5)、V_(10)、V_(20)、V_(30)和V_(40))的剂量曲线基本一致;铅门跟随技术组中PTV和肺的γ通过率比铅门固定技术组中分别小0.55%和0.05%,铅门跟随技术组中虚拟器官V_(5)、V_(10)、V_(20)、V_(30)和V_(40,Spared)的γ通过率比铅门固定技术组中分别小0.04%、0.04%、0.09%、0.13%和0.09%,但差异均无统计学意义(P>0.05);铅门跟随技术组中心脏的γ通过率比铅门固定技术组的大0.09%,但差异无统计学意义(P>0.05)。结论铅门跟随技术对食管癌调强放疗的计划质控和放射性肺炎剂量体积指标无明显影响,两方法均可用于临床治疗。 展开更多
关键词 食管癌 调强放疗 放射性肺炎 计划质控
下载PDF
Endogenous sulfur dioxide attenuates hypoxia-induced pulmonary artery hypertension via promoting the eNOS/cGMP/PKG cascade and downregulating the RhoA/ROCK pathway
3
作者 CHEN Si-yao ZHANG Chong-jian +4 位作者 WU Yi-jin FANG Miao-xian xiong wei-ping LEI Li-ming HE Biao-chuan 《South China Journal of Cardiology》 CAS 2021年第3期191-202,共12页
Endogenous sulfur dioxide(SO_(2) )is a novel gasotransmitter involved in the pathophysiologic process of pulmonary artery hypertension(PAH).However,the molecular pathways on which endogenous SO_(2) impact remains uncl... Endogenous sulfur dioxide(SO_(2) )is a novel gasotransmitter involved in the pathophysiologic process of pulmonary artery hypertension(PAH).However,the molecular pathways on which endogenous SO_(2) impact remains unclarified.Methods In the present study,the regulatory role of endogenous SO_(2) in the pathogenesis of PAH and its associated molecular mechanisms were investigated.A Wistar rat model of PAH induced by hypoxic exposure was established.Endogenous SO_(2) content in rat plasma and rat lungs,mean PAH,ratio of right ventricular/(left ventricular+septum)[RV/(LV+SP)]and body weight of Wistar rats were examined.Protein expression of aspartate aminotransferase 1(AAT1),endothelial nitric oxide synthase(e NOS)and Rho-associated coiled kinase(ROCK)in rat lung tissues were determined by western blot.Activation of AAT1 and Ras homolog gene family member A(Rho A)in rat lungs were detected by assay kits according to manufacturers’instructions.The concentration of nitric oxide(NO),level of cyclic guanosine monophosphate(c GMP)and activity of protein kinase G(PKG)in rat lung tissues after exposure to hypoxic conditions or treatment with SO_(2) donor were also examined using commercial kits.Results Our data showed that the endogenous SO_(2) /AAT1 pathway was markedly downregulated in rats with PAH induced by hypoxic exposure.However,SO_(2) donor upregulated the endogenous SO_(2) pathway and attenuated PAH.Further investigation revealed that in the PAH model,the e NOS/c GMP/PKG cascade was downregulated and the Rho A/ROCK pathway was upregulated,which could be reversed by SO_(2) donor.Conclusions In conclusion,the endogenous SO_(2) /AAT1 pathway might protect against the development of hypoxic exposure induced PAH by promoting the e NOS/c GMP/PKG cascade and downregulating Rho A/ROCK pathway. 展开更多
关键词 sulfur dioxide pulmonary artery hypertension ENOS RHOA
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部